WASHINGTON (Reuters) - Roche Holding AG had ended its study of heart transplant patients after a higher than expected rate of acute organ rejection was found, U.S. health regulators said on Thursday.
The FDA said patients in the trial were switched from a regimen of calcineurin inhibitor and the company's immunosupressant drug CellCept to the immunosupressant drug sirolimus and CellCept.
Sirolimus is sold by Wyeth under the brand name Rapamune.
KAILUA, Hawaii (Reuters) - A wing of al Qaeda claimed responsibility on Monday for a failed Christmas Day attack on a U.S.-bound passenger plane, and President Barack Obama vowed to bring "every element" of U.S. power against those who threaten Americans' safety. | Video
As Russia's memories of crippling economic times fade, are reforms disappearing along with them? Commentary
One of the world's largest organ trade hubs is moving to stop the living from cashing in their body parts. Full Article
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
